- Deadline for abstract submission: 12 October 2026.
- Abstract acceptance notification: 10 November 2026.
An abstract acceptance email only confirms that your abstract has been accepted. Oral or poster presentation invitations are determined separately by the conference chairs, and you will receive an additional email with the presentation result.
- Types of Submissions
- Accepted: Original research abstracts; systematic reviews or meta-analyses abstracts (must comply with PRISMA 2020).
- Not accepted: Narrative, scoping, comparative, perspective, opinion, or essay-style reviews. - Content Requirements
- Length: 200–300 words.
- Structure: Introduction, Methods, Results, Conclusions.
- Language: Clear, publication-ready English.
- Originality: Must be original and unpublished; previously published abstracts will not be considered.
3. Authorship
All listed authors must have made substantial contributions to the work, participated in drafting or critically revising the abstract, and approved the final version. The submitting (presenting) author is responsible for ensuring that all co-authors have reviewed and approved the submission, including its content and authorship order.
Requests for changes to authorship (including the addition, removal, or reordering of authors) after submission must be submitted using a signed Authorship Change Form, with written consent from all affected authors. Such requests are subject to review and approval by the Conference Organizing Team. All authors share collective responsibility for the accuracy, integrity, and ethical compliance of the submitted work.
Authors may submit multiple abstracts, but only one abstract per author may be selected for an oral presentation.
1. Each abstract must designate one presenter. To change the presenter, please contact us after you receive the oral/poster presentation invitation.
2. Only live presentations are accepted.
3. Presenters who do not attend the live session will not be eligible for awards or presentation certificates.
- Use a clear and logical structure, typically Introduction-Methods-Results&Discussion structure (IMRaD) or a field-appropriate alternative;
- Emphasize the relevance of the work;
- Support key findings with clear figures or tables where appropriate;
- Conclude with a critical interpretation of the results and their impact.
- Brief introduction outlining the research objective;
- Concise methodology summary;
- Main results, supported by clear, well-labeled figures or tables where appropriate;
- Short conclusion summarizing key findings and their relevance.
Dimensions (cm): 84.1 × 118.9 (A0 - portrait)
Resolution:300 dpi
Pixel size (portrait, 300 dpi):9933 × 14043 px
Minimum font size:≥24
Any request concerning abstract or proceedings paper withdrawal should be communicated to the Conference Organizing Team as early as possible, preferably prior to final acceptance and confirmation of the conference program. Please note that once abstracts are published in the Conference Report or once Proceedings papers are published in the Proceedings journal and assigned a DOI, they become part of the permanent scholarly record and cannot be fully removed.
AI policy
The responsible use of generative AI tools in the preparation of abstracts, posters, and presentations is permitted; however, any such use must be clearly disclosed, specifying the tool employed and its role. Authors retain full responsibility for the accuracy and integrity of their work.
Potential Conflicts of Interest
Authors must disclose any financial, professional, or personal relationships that could reasonably be perceived as influencing the integrity, interpretation, or presentation of their work. Failure to provide accurate disclosures may result in the removal of the abstract from the conference program and associated publications.
If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
1. Copyright Ownership
In accordance with Swiss copyright law, you, as the author, are the original creator of your work and retain full copyright ownership of your submitted abstract.
2. License Grant
By submitting your abstract for publication on the Sciforum.net platform, you grant MDPI, the platform’s publisher, a worldwide, royalty-free, non-exclusive license to:
- Publish, reproduce, and distribute the abstract online.
- Make the abstract publicly available in connection with the conference.
3. Author’s Retained Rights
This license is non-exclusive. As you retain full copyright, you are free to:
- Reuse, republish, and build upon your work in any way.
- Develop the abstract into a full paper for submission to other journals or publications.
- Enter into subsequent agreements, including granting an exclusive license or transferring copyright to another publisher for a future version of the work.
4. Author’s Responsibility
You remain solely responsible for complying with the policies of any other journal or publisher to which you may submit a subsequent version of your work, particularly concerning prior publication rules. MDPI and Sciforum.net bear no responsibility for any conflicts arising from your future submissions.